Sinusitis – Indication Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) Market -
SINUSITIS –INDICATION PIPELINE INSIGHT
• The sinus is described as a connected system of air-filled cavities containing blood or a cavity within the bone that is located in the skull.
• Sinusitis is known to be a medical condition that is characterized by inflammation along the lining of sinus, which leads to nose blockage and also stops the mucus drainage.
• Thus the mucus starts building up in the nose, thereby filling the sinus cavities that are caused by bacteria, viruses, fungi, and microbes.
• The symptoms of sinus infections include discolored nasal discharge, nasal obstruction, facial pain, pain around the eye, forehead, nose, forehead, and root of teeth. Sinusitis infection will be diagnosed through the presence of polyps, physical examination of nasal mucosa color and characteristics, the presence of polyps, and the structure of the nasal septum. Sinusitis is of three different types: acute sinusitis, sub-acute sinusitis, and chronic sinusitis.
• The sinusitis treatment includes the use of analgesics, corticosteroids, antihistamines, antibiotics, quinolones, sulphonamides, and surgery.
• Antibiotics that are used to treat bacterial sinusitis are penicillin, cephalosporin, and a macrolide. Corticosteroids act by reducing mucosa membrane swelling. Corticosteroids most commonly used in sinusitis include fluticasone, prednisone, mometasone, and triamcinolone.
• Sulphonamides that are used to treat bacterial sinusitis include sulfamethoxazole and trimethoprim. Surgery is the last option for chronic sinusitis patients.
• The two types of surgical procedures like endoscopy and balloon sinus plasty are used for sinus infections. Some of the drugs that are in phase 3 of clinical trials include Budesonide applied as a nasal spray in the therapy of chronic rhinosinusitis by Pari pharma GmbH Industry; Omalizumab applied as nasal polyps in chronic rhinosinusitis treatment by Hoffmann-La Roche industry, and others like Reslizumab, Xylitol. And some of the drugs in phase 2 trials include Etoximab by AnatysBio inc, and others like Itraconazole, Benralizumab. Less number of studies is found to be in early phase and phase 1 clinical trial development.
• Combination of nasal wash and nasal steroid sprays are highly effective for treating sinus problems and some of the steroid nasal sprays that are available in market include Flonase®, Veramyst® (fluticasone), Nasacort® (triamcinolone), Nasacort AQ®, Nasarel® (flunisolide), Rhinocort® (budesonide), Nasonex® (mometasone). The factors that contribute to the growth of sinusitis treatment market include demand for diagnostic test and antibiotics, the patient education programs for increasing awareness among the public people by companies and hospitals.
• Increasing number of people suffering from common cold, Advancement in technology and no age specificity are the additional factors that are going to drive the market over the forecasted period. Although significant revenue is expected to generate throughout the forecast period for the sinusitis treatment market, the accessibility of the test and higher cost of diagnostic test for sinusitis is considered as a major challenge for the overall growth of the market of sinusitis treatment. The clinical trial for drugs is known to be the major challenge for pharmaceutical companies.
• The sinus is described as a connected system of air-filled cavities containing blood or a cavity within the bone that is located in the skull.
• Sinusitis is known to be a medical condition that is characterized by inflammation along the lining of sinus, which leads to nose blockage and also stops the mucus drainage.
• Thus the mucus starts building up in the nose, thereby filling the sinus cavities that are caused by bacteria, viruses, fungi, and microbes.
• The symptoms of sinus infections include discolored nasal discharge, nasal obstruction, facial pain, pain around the eye, forehead, nose, forehead, and root of teeth. Sinusitis infection will be diagnosed through the presence of polyps, physical examination of nasal mucosa color and characteristics, the presence of polyps, and the structure of the nasal septum. Sinusitis is of three different types: acute sinusitis, sub-acute sinusitis, and chronic sinusitis.
• The sinusitis treatment includes the use of analgesics, corticosteroids, antihistamines, antibiotics, quinolones, sulphonamides, and surgery.
• Antibiotics that are used to treat bacterial sinusitis are penicillin, cephalosporin, and a macrolide. Corticosteroids act by reducing mucosa membrane swelling. Corticosteroids most commonly used in sinusitis include fluticasone, prednisone, mometasone, and triamcinolone.
• Sulphonamides that are used to treat bacterial sinusitis include sulfamethoxazole and trimethoprim. Surgery is the last option for chronic sinusitis patients.
• The two types of surgical procedures like endoscopy and balloon sinus plasty are used for sinus infections. Some of the drugs that are in phase 3 of clinical trials include Budesonide applied as a nasal spray in the therapy of chronic rhinosinusitis by Pari pharma GmbH Industry; Omalizumab applied as nasal polyps in chronic rhinosinusitis treatment by Hoffmann-La Roche industry, and others like Reslizumab, Xylitol. And some of the drugs in phase 2 trials include Etoximab by AnatysBio inc, and others like Itraconazole, Benralizumab. Less number of studies is found to be in early phase and phase 1 clinical trial development.
• Combination of nasal wash and nasal steroid sprays are highly effective for treating sinus problems and some of the steroid nasal sprays that are available in market include Flonase®, Veramyst® (fluticasone), Nasacort® (triamcinolone), Nasacort AQ®, Nasarel® (flunisolide), Rhinocort® (budesonide), Nasonex® (mometasone). The factors that contribute to the growth of sinusitis treatment market include demand for diagnostic test and antibiotics, the patient education programs for increasing awareness among the public people by companies and hospitals.
• Increasing number of people suffering from common cold, Advancement in technology and no age specificity are the additional factors that are going to drive the market over the forecasted period. Although significant revenue is expected to generate throughout the forecast period for the sinusitis treatment market, the accessibility of the test and higher cost of diagnostic test for sinusitis is considered as a major challenge for the overall growth of the market of sinusitis treatment. The clinical trial for drugs is known to be the major challenge for pharmaceutical companies.
